Sleep Quality and Quantity in Caregivers of Children with Type 1 Diabetes Using Closed-Loop Insulin Delivery or a Sensor-Augmented Pump
Authors' conclusion
Results from this study suggest that sleep quality and quantity in parents of children using CL were not significantly different to those using SAP. Considering effect sizes and the direction of the non-significant results, CL treatment could be associated with better sleep quality in the primary caregiver. However, further research is needed to confirm these findings. This trial is
Study context
- Population
- Parents (caregivers) of very young children aged 1 to 7 years with T1D (child mean age 4.7, SD 1.7)parents of 21 children
- Participants
- 40 parents
- Comparison
- Closed-loop system vs sensor-augmented pump therapy in children with T1D
- CLn = 10
- Sensor-augmented pump (SAP)n = 11reference
- Primary endpoint
- Caregiver sleep quality and quantity (sleep diaries, accelerometers, questionnaires)
- Follow-up
- Single post-randomisation time point during 16-week arm
Methodological detailssingle post-randomisation time point
- Single post-randomisation time point
Primary result
As reported in the abstract
- Mixed pattern of results; group differences not statistically significant at p < 0.05
- Sleep diary (caregiver 1): CL vs SAP shorter sleep duration but better sleep quality, fewer awakenings, less wake after sleep onset (WASO) (non-significant direction)
- Actiwatch (caregiver 1): CL vs SAP shorter sleep latency, greater sleep efficiency, less WASO (non-significant direction)
- Pittsburgh Sleep Quality Index: better sleep quality for caregiver 1 of CL vs SAP (non-significant direction)
- Main analyses in caregiver 1; caregiver 2 in supplementary analyses
Original publication
Sleep Quality and Quantity in Caregivers of Children with Type 1 Diabetes Using Closed-Loop Insulin Delivery or a Sensor-Augmented Pump. Pediatr Diabetes. Published 13 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →